Position in ERAS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$212,702
+$81,617 QoQ
Shares Held
13,146
-62.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAILARD, INC. holds $21,826,952 across 19 Biotechnology names. ERAS ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,862 | $16,906,897 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,378 | $2,609,977 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
1,400 | $279,510 | |
| 4 | INVA |
Innoviva, Inc.
|
10,933 | $254,738 | |
| 5 | ERAS |
Erasca, Inc.
This page
|
13,146 | $212,702 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
14,700 | $137,004 | |
| 7 | NKTX |
Nkarta, Inc.
|
63,400 | $133,774 | |
| 8 | ARTV |
Artiva Biotherapeutics, Inc.
|
20,700 | $133,308 |
All Filings in ERAS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,702 | 13,146 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $131,085 | 35,238 | Shares | Sole | 2026-02-04 | |
| 2023-12-31 | $106,500 | 50,000 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||